Ryaby, James T.; Sheller, Michael R.; Levine, Benjamin P.; Bramlet, Dale G.; Ladd, Amy L.; Carney, Darrell H.
November 2006
Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p132
Academic Journal
The thrombin peptide, TP508, also known as Chrysalin (OrthoLogic, Tempe, Arizona), is a twenty-three-amino-acid peptide that represents a portion of the receptor-binding domain of the native human thrombin molecule that has been identified as the binding site for a specific class of receptors on fibroblasts and other cells. Preclinical studies with this peptide have shown that it can accelerate tissue repair in both soft and hard tissues by mechanisms that appear to involve up-regulation of genes that initiate a cascade of healing events. These events include recruitment and activation of inflammatory cells, directed migration of cells (chemotaxis), cell proliferation, elaboration of extracellular matrix, and accelerated revascularization of the healing tissues. Early preclinical dermal wound-healing studies showed that TP508 accelerated healing of both incisional wounds and full-thickness excisional wounds in normal and ischemic skin. In all of these studies, the accelerated healing was associated with increased neovascularization across the incision or in the granulating wound bed. Studies in a rat fracture model have also shown that TP508 accelerates the rate of fracture repair. Gene array analysis of fracture callus from control and TP508-treated fractures indicated that TP508 treatment was associated with an up-regulation of early response elements, inflammatory mediators, and genes related to angiogenesis. Similar to what had been seen in dermal wounds, histology from rat fracture callus twenty-one days after treatment indicated that fractures treated with TP508 had significantly more large functional blood vessels than did fractures in the control animals. In vitro studies support these in vivo data and indicate that TP508 may have a direct angiogenic effect by promoting the rate of new vessel growth. The results from phase-1 and phase-2 human clinical studies have shown a positive stimulatory effect of TP508 in the healing of diabetic ulcers and in the repair of fractures to the distal aspect of the radius. Collectively, these studies suggest that TP508 accelerates tissue repair by initiating a cascade of events that lead to an increased rate of tissue revascularization and regeneration.


Related Articles

  • Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies. Daniel Tee; Joseph DiStefano III // Journal of Cancer Research & Clinical Oncology;Jan2004, Vol. 130 Issue 1, p15 

    Tumor cells secrete diffusible substances collectively called tumor angiogenic factors (TAFs), most notably vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which in turn stimulate endothelial cell migration and thus angiogenesis, or new blood vessel...

  • IL-17RA Signaling Amplifies Antibody-Induced Arthritis. Sadik, Christian D.; Kim, Nancy D.; Alekseeva, Elena; Luster, Andrew D. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Objective: To investigate the role of IL-17RA signaling in the effector phase of inflammatory arthritis using the K/BxN serum transfer model. Methods: Wild-type and Il17ra-/- mice were injected with serum isolated from arthritic K/BxN mice and their clinical score was recorded daily. Mice were...

  • Launching a leaky vessel. Schubert, Charlotte // Nature Medicine;Mar2006, Vol. 12 Issue 3, p279 

    The article presents a study on peptide that act as inflammatory mediator in the blood vessels during infection. The group of protein is imbibing lots of fluid and neutrophils in the blood stream as a systematic inflammatory response on sepsis. The permeability of the vessel is also influenced...

  • Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases. Sulochana, K. N.; Ge, R. // Current Pharmaceutical Design;Jul2007, Vol. 13 Issue 20, p2074 

    Angiogenesis is regulated by stimulators and inhibitors and involve multiple biological processes including endothelial cell proliferation, migration, cell-cell and cell-matrix adhesion, assembly into tube structures as well as apoptosis. Designing and developing peptides for therapeutic...

  • CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis. Rupprecht, Tobias A.; Koedel, Uwe; Muhlberger, Beatrice; Wilske, Beatrice; Fontana, Adriano; Pfister, Hans-Walter // Journal of Neurology;Jul2005, Vol. 252 Issue 7, p820 

    We investigated the role of the CXCR3 chemokine CXCL11 (I–TAC) for leukocyte recruitment to the CSF in neuroborreliosis (NB). CXCL11 levels in the CSF of 17 patients with acute NB were elevated compared with 20 non–inflammatory controls (100.1 vs. 54.1pg/ml, p = 0.002). Using a...

  • Regulation of FGF receptor-2 expression by transcription factor E2F-1. Tashiro, Etsu; Minato, Yusuke; Maruki, Hiroko; Asagiri, Masataka; Imoto, Masaya // Oncogene;8/28/2003, Vol. 22 Issue 36, p5630 

    Fibroblast growth factors (FGF) and their receptors play an important role in cell proliferation, angiogenesis and embryonal development. In this study, we show that expression of the FGF receptor-2 (FGFR-2) protein is induced in the mid-to-late G1 phase of the cell cycle in serum-starved mouse...

  • Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis. Hussain, Sajjad; Slevin, Mark; Ahmed, Nessar; West, David; Choudhary, Muhammad Iqbal; Naz, Humera; Gaffney, John // BMC Cell Biology;2009, Vol. 10, Special section p1 

    Background: Angiogenesis, the growth of new blood vessels from the pre-existing vasculature is associated with pathological processes, in particular tumour development, and is a target for the development of new therapies. We have investigated the anti-angiogenic potential of two naturally...

  • Enhanced Collateral Growth by Double Transplantation of Gene-Nucleofected Fibroblasts in Ischemic Hindlimb of Rats. Ziyang Zhang; Slobodianski, Alex; Ito, Wulf D.; Arnold, Astrid; Nehlsen, Jessica; Shaoxiang Weng; Lund, Natalie; Jihong Liu; Egaña, José-Tomás; Lohmeyer, Jörn A.; Müller, Daniel F.; Machens, Hans-Günther // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: Induction of neovascularization by releasing therapeutic growth factors is a promising application of cellbased gene therapy to treat ischemia-related problems. In the present study, we have developed a new strategy based on nucleofection with alternative solution and cuvette to...

  • Neridronate inhibits angiogenesis in vitro and in vivo. Ribatti, D.; Nico, B.; Mangieri, D.; Maruotti, N.; Longo, V.; Vacca, A.; Cantatore, F. P. // Clinical Rheumatology;Jul2007, Vol. 26 Issue 7, p1094 

    The effects of the amino-bisphosphonate neridronate on endothelial cell functions involved in angiogenesis, namely, proliferation and morphogenesis on Matrigel were tested in vitro, whereas its effects on angiogenesis were studied in vivo, by using the chick embryo chorioallantoic membrane (CAM)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics